Meditation and Hypnosis for Chronic Depressed Mood

This study has been completed.

First Received: September 12, 2005 Last Updated: September 23, 2005 History of Changes

Sponsored by:	Stanford University
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00226863

Purpose

This study examined whether meditation or group psychotherapy including hypnosis plus education, compared to an educational control, would ameliorate long-term depressed mood.

Condition	Intervention	Phase
Long Term Depressed Mood	Behavioral: meditation plus education Behavioral: group psychotherapy with hypnosis plus education Behavioral: education	Phase III

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment

Resource links provided by NLM:

MedlinePlus related topics: Depression

U.S. FDA Resources

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Currently meeting DSM-IV criteria for a chronic depressive disorder, with the requirement that depressive symptoms had to have lasted for at least 2 years without a remission of 2 months or more.
Being 18 years of age or older.
Being sufficiently proficient in English to be able to participate in group therapy.
Being able to attend weekly meetings at Stanford.

Exclusion Criteria:

Concurrent bipolar disorder or severe depressive disorder (this latter was determined in supervision for the SCID interviews).
Presence or history of psychosis.
A current primary diagnosis of panic disorder, generalized anxiety disorder, or PTSD.
A current primary diagnosis of drug or alcohol dependency or abuse (within the last 3 months).
Serious suicidal risk, as defined by:
Current suicidality, i.e., beyond simple ideation (e.g., making threats or attempts; gathering means; has a plan); OR
Serious prior attempts (bodily harm; gathered means; hospitalization).
Has a significant medical condition that could interfere with participation in meditation/yoga.
Current participation in psychotherapy or a meditation group.
Has started (or changed level or type of) prescribed antidepressant medication or St. John’s Wort in the previous 3 months.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00226863

Sponsors and Collaborators

Stanford University

Investigators

Study Director:	Lisa D. Butler, Ph.D.	Stanford University
Principal Investigator:	David Spiegel, M.D.	Stanford University

More Information

No publications provided

Study ID Numbers:	1HSA698
Study First Received:	September 12, 2005
Last Updated:	September 23, 2005
ClinicalTrials.gov Identifier:	NCT00226863 History of Changes
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Depression
Depressive Disorder
Behavioral Symptoms

Additional relevant MeSH terms:

Depression
Behavioral Symptoms

ClinicalTrials.gov processed this record on September 11, 2009